+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GLAXO

GlaxoSmithKline Pharmaceuticals Share Price

₹2,963.40 +31.7 (1.08%)
New 52W High in past week

25 Aug, 2026 3:54 PM (IST)

GlaxoSmithKline Pharmaceuticals live price: ₹2,963.40. It opened at ₹2,954 vs previous close ₹2,932; intraday high/low: ₹3,010/₹2,918. The 50 & 200 DMA stand at ₹2,600.70/₹2,518.90.

GlaxoSmithKline Pharmaceuticals Performance

  • Today's Low
  • ₹2,918
  • Today's High
  • ₹3,010
  • 52 Week Low
  • ₹2,088
  • 52 Week High
  • ₹3,055
  • Open Price₹2,954
  • Previous Close₹2,932
  • Volume409,531
  • 50 DMA₹2,600.70
  • 100 DMA₹2,519.80
  • 200 DMA₹2,518.90

GlaxoSmithKline Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 17.86%
  • Over 3 Month + 28.46%
  • Over 6 Month + 13.18%
  • Over 1 Year + 5.88%

Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!

Invest Now

GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 47
  • PEG Ratio
  • 3.8
  • Market Cap Cr
  • 50,202
  • P/B Ratio
  • 20
  • Average True Range
  • 86.6
  • EPS
  • 63.1
  • Dividend Yield
  • 1.9
  • MACD Signal
  • 120.5
  • RSI
  • 71.75
  • MFI
  • 93.08

Latest Stock News Updates

New launches, innovative portfolio set to drive gains for GSK Pharma stock

Brokerages expect strong near-term growth on traction in innovative products and new launches, though some see limited upside after the stock's recent outperformance

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30

As per attachment

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper Publication

As per attachment

GlaxoSmithKline Pharmaceuticals Financials

GlaxoSmithKline Pharmaceuticals Technicals

EMA & SMA

Current Price
₹2,963.40
+ 31.7 (1.08%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹2,757.40
  • 50 Day
  • ₹2,600.70
  • 100 Day
  • ₹2,519.80
  • 200 Day
  • ₹2,518.90

Resistance and Support

2963.67 Pivot Speed
  • R3 3,102.10
  • R2 3,056.10
  • R1 3,009.70
  • S1 2,917.30
  • S2 2,871.30
  • S3 2,824.90

GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-03 Quarterly Results
2026-05-13 Audited Results & Dividend
2026-02-09 Quarterly Results
2025-11-06 Quarterly Results
2025-08-01 Quarterly Results
Date Purpose Remarks
2026-05-29 FINAL Rs.57.00 per share(570%)Final Dividend
2025-05-30 FINAL Rs.42.00 per share(420%)Final Dividend
2024-11-07 INTERIM Rs.12.00 per share(120%)Interim Dividend
2024-05-31 FINAL Rs.32.00 per share(320%)Final Dividend
2023-06-30 FINAL Rs.32.00 per share(320%)Final Dividend
View GlaxoSmithKline Pharmaceuticals Dividend History Arrow

GlaxoSmithKline Pharmaceuticals Shareholding Pattern

75%
12.42%
4.87%
4.79%
2.94%

About GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. View More
  • NSE Symbol
  • GLAXO
  • BSE Symbol
  • 500660
  • ISIN
  • INE159A01016

Similar Stocks to GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals FAQs

GlaxoSmithKline Pharmaceuticals share price is ₹2,963 As on 25 August, 2026 | 20:55

The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹50201.8 Cr As on 25 August, 2026 | 20:55

The P/E ratio of GlaxoSmithKline Pharmaceuticals is 47 As on 25 August, 2026 | 20:55

The PB ratio of GlaxoSmithKline Pharmaceuticals is 20 As on 25 August, 2026 | 20:55

The 52 week High & Low of GlaxoSmithKline Pharmaceuticals is ₹3054.9/₹2088.1 respectively As on 25 August, 2026 | 20:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23